Abstract
In recent years genetic modification of cells has promised to revolutionize medicine by offering novel therapeutic approaches in a range of diseases. However, lack of effective means of delivery has so far limited therapeutic applications. Polymeric vectors have been a much-investigated area of non-viral gene delivery but until recently the focus has been on plasmid DNA (pDNA) delivery. Current research suggests that polymer-mediated siRNA delivery is gaining momentum. Previous work in our group has resulted in an effective non-cytotoxic alternative to PEI for pDNA delivery in the lungs, using the reductive environment of the cytoplasm as a means of triggering polymer degradation. Here we present a review covering delivery of either pDNA or siRNA to the lungs, using different polymers. We critically review the key structural polymer characteristics for efficient gene lung delivery. We conclude that for highly efficient pulmonary gene delivery, non-toxic, bioresponsive polymers are required transfer the nucleic acid and genetically modify the lung tissue.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
